Market Introduction
Cartilage plays an important role in smooth mechanical movements of bones and muscles. Degeneration of cartilage can lead to pain and chronic inflammation in joints. Furthermore, this damaged cartilage can potentially influence quality of the life. Continual research and development is leading to innovation of new techniques and methodologies to deal with damages cartilages. Some of these techniques comprises joint replacement, cell therapies, and chondroplasty amongst others.
Market Overview and Dynamics
The South & Central America cartilage degeneration market is expected to reach US$ 1,195.57 million by 2027 from US$ 959.32 million in 2019. The market is anticipated to grow at a CAGR of 2.9% during 2019–2027. The increasing prevalence of sports injuries and obesity are the major factors expected to boost the growth of the cartilage degeneration market in South & Central America. However, the market is likely to get impacted by the risk factor such as high cost of cartilage therapies during the forecast period.
Key Market Segments
In terms of procedure type, the joint replacement segment accounted for the largest share of the South & Central America cartilage degeneration market in 2019. In terms of application knee segment accounted for the largest share of the South & Central America cartilage degeneration market in 2019. In terms of end user, the hospitals and specialty clinics segment accounted for the largest share of the South & Central America cartilage degeneration market in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the South & Central America cartilage degeneration market report are the World Health Organization (WHO), and others.
Reasons to buy report
- It provides understanding of the South & Central America, cartilage degeneration market landscape and identifies cartilage degeneration market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the South & Central America cartilage degeneration market.
- It helps efficiently plan merger and acquisition, and partnership deals in the cartilage degeneration market by identifying market segments with the most promising probable sales
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of cartilage degeneration market performance of various segments pertaining to the South & Central America cartilage degeneration market.
- It provides cartilage degeneration market revenue forecast of the market based on various segments for the period from 2019 to 2027.
SOUTH & CENTRAL AMERICA CARTILAGE DEGENERATION MARKET SEGMENTATION
By Procedure Type
- Joint Replacement
- Chondroplasty
- Cell-based Cartilage Resurfacing
- Osteochondral Transplant
- Meniscus Transplants
- Others
By Application
- Knee
- Hips
- Others
By End User
- Hospitals and Specialty Clinics
- Ambulatory Surgical Centers
- Academic and Research Institutes
By Country
- Brazil
- Argentina
- Rest of South & Central America
Company Profiles
- B. Braun Melsungen AG
- Smith & Nephew
- Stryker Corporation
- CartiHeal, Inc
- Vericel Corporation
South and Central America Cartilage degeneration Market Strategic Insights
South and Central America Cartilage degeneration Market Report Highlights
| Report Attribute | Details |
| Market size in 2019 | US$ 959.32 Million |
| Market Size by 2027 | US$ 1,195.57 Million |
| CAGR (2019 - 2027) | 2.9% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Procedure Type
|
|
Regions and Countries Covered
|
|
| South and Central America | Brazil, Argentina, Rest of South and Central America |
| Market leaders and key company profiles |
|
South and Central America Cartilage degeneration Market Country and Regional Insights
